FDA approves updated COVID-19 vaccines amid rising cases and hospitalizations 

Share on facebook
Share on twitter
Share on linkedin
Share on email

JANS – The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer/BioNTech in response to the surge in cases and hospitalizations. Both manufacturers have reported that their vaccines demonstrate effectiveness against the currently dominant EG.5 strain in the United States.

CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week.

The new release coincides with a late summer surge in COVID-19 hospitalizations and growing concerns over the potential impact of respiratory viruses, including COVID-19, influenza, and respiratory syncytial virus, in the upcoming fall and winter seasons.

Republish This Story

Copy and Paste the below text.

FDA approves updated COVID-19 vaccines amid rising cases and hospitalizations 

By Jackson Advocate News Service
September 18, 2023